Abstract

Seaweed is an inexhaustible source of chemical compounds of varied biological activity, characterized by the synthesis of various secondary metabolites that have antioxidant, anti-inflammatory, anticancer and antidiabetic activity. This study focused on the species Plocamium cartilagineum in search of a potential inhibitor of the enzyme α-D-glucosidase associated with type 2 diabetes mellitus. In recent years, bioautographic assays in TLC have become an effective tool to identify the presence of a possible enzyme inhibitor in a short time. The extract of P. cartilagineum was evaluated against the enzyme α-D-glucosidase and 4 compounds were isolated that showed important inhibitory activity of the enzyme by TLC. Pure compounds were identified by employing IR, EIMS, NMR and compared with authentic samples. The CH2Cl2 extract of P. cartilagineum shows bioactive compounds, which were identified as: Mertensene; Violacene; 1S,2S,4R,5R)-1,2,4-trichloro-5-((E)-2-chlorovinil)-1,5-dimethyl cyclohexane and (1R,2S,4S,5S)-1,2,4-trichloro-5-((E)-2-chlorovinyl)-1,5-dimethylcyclohexane.